Mylan might or might not have good news for people who need EpiPens. They provide quick injections to protect against potentially deadly anaphylactic shock from bee stings, peanut allergies and other sources. The drug company is still increasing the price of two EpiPens to $600 — while it also produces a so-called "generic" for $300. Andrew Pollack covers the business and science of biotechnology for the New York Times.
Drug-maker Mylan and its $300 "generic" EpiPen
Credits
Guest:
Andrew Pollack - New York Times
Host:
Warren Olney
Producers:
Sáša Woodruff,
Paul von Zielbauer,
Jenny Hamel
